Best Grants for International Development in Hawaii

GBA1 Parkinson's Disease Research Catalyst Program

The GBA1-PD Research Catalyst Program seeks to build a deeper, globally integrated understanding of GBA1-associated Parkinson’s disease by aligning efforts across geographies and maximizing the value of shared datasets and research assets. Funding will support hypothesis- driven projects with an emphasis on integrative, cross-cohort analyses and the systematic characterization and standardization of models to enable broad use by the research community.

Funding

Duration: 12 to 24 months

Award Amount: Up to $300,000. Requested support should be commensurate with work proposed.

These budgets include direct and indirect costs. For academic and for-profit institutions, no more than 15% or 10%, respectively, may go to indirect costs. 

Community Foundation of the Fox River Valley

The Community Foundation of the Fox River Valley is a collection of individual funds and resources given by local citizens to enhance and support the quality of life in the Fox River Valley of Illinois.

We are a tax-exempt public charity that allows individuals, businesses, and non-profit organizations to establish permanent endowments and temporary funds within the confines of one large foundation.

Foundation funds are used to provide grants to non-profit organizations and scholarships to area students. The Foundation also hosts a Youth Engagement in Philanthropy (YEP) program, which helps high school students learn more about philanthropy and empowers them to make a difference in the community.

The Community Foundation of the Fox River Valley serves the City of Aurora, Kane County, and Kendall County within the State of Illinois.

Kendall’s Kindness Scholarship Fund

The Kendall’s Kindness Scholarship Fund was created by the Maffia Family in loving memory of their daughter, sister, niece, and granddaughter Kendall Marie Maffia (6/12/2000-10/11/2021). This scholarship has been established to provide two $1,000 scholarships to graduating seniors from either St. Charles North High School or St. Charles East High School. The Kendall’s Kindness Scholarship is intended for students who are planning to continue their education at a 4-year college and will major in an Arts-related degree.

Kendall’s family and friends want Kendall’s kind-hearted, gentle, loving, and passionate spirit to continue to impact others. The Kendall’s Kindness Scholarship Fund has been established to support young people who are interested in art, have a passion for their community, and exhibit the gentle spirit and kindness that Kendall showed others every day.

The monetary value of each scholarship award varies depending upon the amount available in each individual scholarship fund. The most common scholarship award amount is $1,000 for a single year. Scholarships are designated as non-renewable one-year awards or renewable multi-year awards depending upon the scholarship fund criteria, as established by the donor of the scholarship fund.

Accelerating the Development of Combined CGM–Pump Devices

A combined continuous glucose monitor (CGM) and insulin pump device represents an innovative approach to simplifying diabetes management by integrating two essential technologies into a single device. This approach has the potential to improve quality of life for people with type 1 diabetes (T1D) by reducing the burden associated with wearing and managing multiple devices.

Despite this promise, the development of combined CGM–pump devices presents technical and commercialization challenges. These include the need for further advances in device compatibility and lifespan, system reliability, and scalable manufacturing, while maintaining affordability and broadaccessibility. In addition, a potential insulin dilution effect may require adjustment of the CGM algorithm.

Breakthrough T1D invites applications for research and development projects that address key technical, clinical, and translational challenges related to combined CGM–pump devices, with the goal of accelerating their development and improving outcomes for people living with T1D.

In response to this announcement, applications may request up to a total of $900,000 USD for up to three years. 

The FY26 Breast Cancer Research Program's Transformative Breast Cancer Consortium Award fosters significant collaborations that aim to revolutionize care for individuals affected by breast cancer. This award supports a multidisciplinary consortium of leading scientists, clinicians, and advocates to tackle major challenges in breast cancer research. Proposals must address at least one of the program's overarching challenges and demonstrate a transformative impact that cannot be achieved by individual investigators alone.

The Universal Application for Adults offers a simplified way for adult students in Elkhart County to apply for six different scholarships with one application. This initiative by the Community Foundation aims to support those pursuing further education, whether returning to school or changing careers. Eligible applicants must have a high school diploma and plan to attend an accredited institution. This program streamlines the scholarship process, making it easier for dedicated learners to access funding opportunities.

The Grady Graves Scholarship Fund, established in 1953, aims to uplift the community by providing scholarships of up to $20,000 for graduating seniors of Crowell High School in Texas. Focused on enhancing health, wealth, and education, this initiative fosters a culture of giving and equity. By partnering with local donors and organizations, the fund plays a vital role in shaping a brighter future for students and the broader community.

The DoW Ovarian Cancer Pilot Award fosters innovative research that challenges existing paradigms in ovarian cancer. It aims to propel groundbreaking discoveries and advancements in the field. Notably, the award prioritizes originality over scientific merit alone, ensuring that innovative ideas are at the forefront. The application process includes a blinded pre-application screening to maintain confidentiality and integrity, encouraging fresh perspectives in ovarian cancer research.

The Jack Ford Shelby Scholarship Fund, established in 1953, supports graduating seniors from Littlefield High School in Texas with scholarships up to $5,000 for pursuing a baccalaureate degree at accredited colleges or universities. This initiative aims to enhance community health and equity by investing in the education of local students, ensuring they have the necessary resources to succeed academically and contribute positively to society.

The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award aims to support impactful research addressing critical needs in ovarian cancer and patient care. It requires a robust research plan with preliminary data and allows for studies across all research phases, excluding clinical trials. A unique Partnering Principal Investigator option encourages collaboration between two PIs to enhance research outcomes beyond individual efforts, promoting innovation in the field of ovarian cancer.

The FY26 Breast Cancer Research Program (BCRP) Breakthrough Award Level 3 supports transformative research aimed at significant advancements in breast cancer treatment. Applicants must address key challenges outlined by the program, ensuring their proposals demonstrate potential for impactful breakthroughs. This funding mechanism, which permits small-scale clinical trials, emphasizes collaboration by requiring research teams to include two breast cancer consumer advocates and allows for a single Principal Investigator or two partnering PIs.

The Emerge Grant, established by the Jeannette Rankin Foundation, supports women and nonbinary individuals aged 25 and older from Georgia and Montana. With grants up to $2,500 annually, recipients can pursue technical, vocational, or degree programs at accredited U.S. institutions. This initiative, rooted in Rankin's legacy, aims to empower those demonstrating financial need. Applicants will be informed about their status, ensuring transparency in the selection process.

The DoW Ovarian Cancer Clinical Trial Award, funded by the U.S. Army Medical Command, aims to accelerate the implementation of clinical trials that significantly impact ovarian cancer treatment. This award supports diverse trial designs, from early proof-of-concept studies to large-scale efficacy trials, evaluating innovative drugs, biologics, and technologies. By fostering research in this critical area, the program seeks to enhance patient outcomes and advance the understanding of ovarian cancer management.

The Jeannette Rankin National Scholar Grant supports women and nonbinary students aged 35 and older, providing up to $2,500 annually for technical or vocational education, associate’s degrees, or first bachelor’s degrees. This grant, renewable for up to five years, aims to empower those facing financial need, fostering better futures for American women. Recipients are selected based on their applications, ensuring that all candidates are informed about their status.

The FY26 Peer Reviewed Medical Research Program Clinical Trial Award promotes the swift initiation of impactful clinical trials for diseases outlined in specific topic areas. It offers two application categories: Clinical Trial Only and Clinical Trial with Planning Phase, supporting various funding levels based on trial phases and participant counts. The total funding of approximately $94.5M aims to support up to 9 applications, with a maximum award period of 4 years, ensuring significant advancements in medical research.

The Samuel R. and Anna Barone Scholarship, established by the Erie County Community Foundation, supports Erie County, Ohio graduating seniors who are first-generation college-bound students. This scholarship aims to assist students demonstrating financial need and academic achievement, with a requirement of a minimum 3.0 GPA. Since 1995, the foundation has been committed to empowering local youth and enhancing community quality of life through education.

Society of Toxicology

Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology. SOT operates under four guiding principles:

• Serving the needs of the scientific discipline and our members to enhance human, animal, and environmental health.
• Life-long learning and intellectual scientific stimulation.
• Diversity of representation in all activities of the Society.
• Integrity.

MDCPSS Early Career Achievement Award

Description

The MDCPSS Early Career Achievement Award recognizes the research accomplishments of young scientists in the early stages of their careers who have demonstrated excellence in toxicological research related to medical devices and/or combination products.

Award Categories

Up to two award recipients will be selected:

• One undergraduate or graduate student
• One postdoctoral fellow or early-career scientist (≤5 years post-graduation)

Award Recognition

• Each recipient will receive a plaque and a monetary award to support travel to the SOT Annual Meeting.
• Awardees will be recognized at the MDCPSS Reception and invited to give a 5-minute overview presentation of their work.

Society of Toxicology

Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology. SOT operates under four guiding principles:

• Serving the needs of the scientific discipline and our members to enhance human, animal, and environmental health.
• Life-long learning and intellectual scientific stimulation.
• Diversity of representation in all activities of the Society.
• Integrity.

MDCPSS Lifetime Career Achievement Award

Description

The MDCPSS Lifetime Career Achievement Award honors a senior investigator whose body of work represents an outstanding and sustained contribution to the field of toxicology as it relates to medical devices and/or combination products.

This award recognizes individuals who have demonstrated scientific excellence, leadership, mentorship, and influence in advancing the safety evaluation, regulatory science, and innovation in this specialized area of toxicology.

Nominations of candidates not selected will be considered for up to two additional years, unless withdrawn by the sponsor.

Award Recognition

The awardee will receive a plaque and will be recognized at the MDCPSS Reception during the SOT Annual Meeting.

The Peter C. Sotus, M.D. Scholarship is part of the Erie Community Foundation's initiative that awarded over $800,000 in scholarships in 2023 to support students pursuing post-secondary education. This scholarship targets high school seniors accepted into accredited institutions, focusing on careers in medicine or music. Preference is given to students born outside the US or children of non-US born parents. This award encourages diversity and support for aspiring professionals.

About The Children’s Heart Foundation

The Children’s Heart Foundation (CHF) is the country’s leading national organization solely dedicated to funding congenital heart defect (CHD) research. The mission of The Children’s Heart Foundation is to fund the most promising research to advance the diagnosis, treatment, and prevention of congenital heart defects. Since its inception, CHF has funded millions of dollars of CHD research across the U.S. and Canada. 

AHA/CHF Congenital Heart Defect Research Awards

The Children’s Heart Foundation partners with the American Heart Association to fund Congenital Heart Defect Research Awards. This collaborative investment of funds provides support for investigators who are actively conducting research directly related to advancing the prevention, diagnosis, and treatment of CHDs, which directly aligns with The Children's Heart Foundation's mission. 

Congenital Heart Defect Funding Opportunities

A multi-year commitment between the American Heart Association (AHA) and Children’s Heart Foundation (CHF) jointly supports Predoctoral Fellowship or Postdoctoral Fellowship investigators actively conducting basic, clinical, population, or translational congenital heart defects research.

Postdoctoral Fellowship

Purpose

To enhance the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor. Recognizing the unique challenges that clinicians, in particular, experience in balancing research and clinical activity, this award mechanism aims to be as flexible as possible to enable applicants to develop academic careers in research alongside fulfilling clinical service commitments.

The trainee and mentor should collaboratively provide a thoughtfully planned, systematic proposal aimed at clearly answering an investigative question in cardiovascular, cerebrovascular or brain health research

• AHA research awards are limited to U.S.-based non-profit institutions, including medical, osteopathic, and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals andothers that can demonstrate the ability to conduct the proposed research.

• Applicants must be AHA Professional Members at the time of proposal submission. The AHA expects all mentors associated with training/mentored research awards to maintain active AHA membership, as well.

• This award is not intended for individuals of faculty rank.

Applicants are not required to reside in the United States for any period before applying for American Heart Association funding. However, applicants must have one of the following designations at the time of proposal submission – not award start date, depending on career stage and each individual’s situation. An awardee must maintain one of the designations listed below throughout the duration of the award. Please consult with your institution’s grant officer.

• U.S. citizen
• Permanent resident
• Pending permanent resident (must have filed Form I-485 for permanent resident status and obtained an I-797C 3 Notice of Action that the application has been received by USCIS and case is pending)
• E-3 Visa - specialty occupation worker
• F-1 Visa – student (for predoctoral and postdoctoral fellows only)
• G-4 Visa - family member of an international organization employee
• H1-B Visa - temporary worker in a specialty occupation
• J-1 Visa - exchange visitor (pre- and postdoctoral fellowships only; all other awardees must obtain an H-1B or equivalent by the award activation date)
• O-1 Visa - temporary worker with extraordinary abilities in the sciences
• TN Visa - NAFTA Professional
• DACA - Deferred Action for Childhood Arrivals

About The Children’s Heart Foundation

The Children’s Heart Foundation (CHF) is the country’s leading national organization solely dedicated to funding congenital heart defect (CHD) research. The mission of The Children’s Heart Foundation is to fund the most promising research to advance the diagnosis, treatment, and prevention of congenital heart defects. Since its inception, CHF has funded millions of dollars of CHD research across the U.S. and Canada. 

AHA/CHF Congenital Heart Defect Research Awards

The Children’s Heart Foundation partners with the American Heart Association to fund Congenital Heart Defect Research Awards. This collaborative investment of funds provides support for investigators who are actively conducting research directly related to advancing the prevention, diagnosis, and treatment of CHDs, which directly aligns with The Children's Heart Foundation's mission. 

Congenital Heart Defect Funding Opportunities

A multi-year commitment between the American Heart Association (AHA) and Children’s Heart Foundation (CHF) jointly supports Predoctoral Fellowship or Postdoctoral Fellowship investigators actively conducting basic, clinical, population, or translational congenital heart defects research.

Predoctoral Fellowship

Purpose

To enhance the integrated research and clinical training of promising students who are matriculated in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global cardiovascular, cerebrovascular and brain health.

• AHA research awards are limited to U.S.-based non-profit institutions, including medical, osteopathic, and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and others that can demonstrate the ability to conduct the proposed research.

• Applicants must be AHA Professional Members at the time of proposal submission. The AHA expects all mentors associated with training/mentored research awards to maintain active AHA membership, as well.

• This award is not for individuals of faculty/staff rank.

Applicants are not required to reside in the United States for any period before applying for American Heart Association funding. However, applicants must have one of the following designations at the time of proposal submission – not award start date, depending on career stage and each individual’s situation. An awardee must maintain one of the designations listed below throughout the duration of the award. Please consult with your institution’s grant officer.

• U.S. citizen
• Permanent resident
• Pending permanent resident (must have filed Form I-485 for permanent resident status and obtained an I-797C 3 Notice of Action that the application has been received by USCIS and case is pending)
• E-3 Visa - specialty occupation worker
• F-1 Visa – student (for predoctoral and postdoctoral fellows only)
• G-4 Visa - family member of an international organization employee
• H1-B Visa - temporary worker in a specialty occupation
• J-1 Visa - exchange visitor (pre- and postdoctoral fellowships only; all other awardees must obtain an H-1B or equivalent by the award activation date)
• O-1 Visa - temporary worker with extraordinary abilities in the sciences
• TN Visa - NAFTA Professional
• DACA - Deferred Action for Childhood Arrivals

The Zachary Adam Giordan-Lascari Memorial Scholarship, offered by the Community Foundation of Southern New Mexico, supports fathers pursuing physical therapy education at accredited institutes. This scholarship aims to assist students from diverse backgrounds, including those with disabilities and members of the LGBTQIA+ community. With a focus on community impact, this fund exemplifies the Foundation's commitment to enhancing educational opportunities and fostering a thriving future for recipients in Southern New Mexico.

Society of Toxicology

Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology. SOT operates under four guiding principles:

• Serving the needs of the scientific discipline and our members to enhance human, animal, and environmental health.
• Life-long learning and intellectual scientific stimulation.
• Diversity of representation in all activities of the Society.
• Integrity.

OTSS Career Achievement Award

Description

The Ocular Toxicology Specialty Section (OTSS) recognizes a Senior Investigator for the achievement or contribution of a particularly influential body of work to the field of ocular toxicology. This award is presented to SOT members who are scientists in academia, industry, or those who have had an impact on regulation in the field.

Nomination is required for this award. The nominator (or self-nomination) should provide a discussion of the role that the candidate’s work has played in any of the below 4 points of criteria. A curriculum vitae and bibliography are required to be included. A letter of recommendation from another investigator in the field is not mandatory but encouraged. Nominations of candidates not selected will be considered for two additional award cycles unless the nomination is withdrawn by the nominator.

Nominations are encouraged with respect to any of the following criteria:

• Contribution to the field of ocular toxicology—depth and breadth of scientific contributions and significance of contributions for advancing the field
• Major influence in the education/training/mentorship of young scientists in the field of ocular toxicology including training in government, industry, or academia
• Leadership and service to the ocular toxicology field including involvement in the Specialty Section or other meetings/organizations related to ocular toxicology
• Influence on regulatory and risk/safety assessment decisions related to ocular toxicology

The award will be announced at the OTSS reception held during the SOT Annual Meeting. The recipient will receive a certificate, monetary award of $1,000 and will give a short (approximately 10 mins) presentation of their work at the OTSS reception held during the SOT Annual Meeting.

Society of Toxicology

Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology. SOT operates under four guiding principles:

• Serving the needs of the scientific discipline and our members to enhance human, animal, and environmental health.
• Life-long learning and intellectual scientific stimulation.
• Diversity of representation in all activities of the Society.
• Integrity.

OTSS Annual “Paper of the Year” Award

Description

Each year, the Taylor & Francis Paper of the Year Award is presented to the best paper in the area of ocular toxicology published in Cutaneous and Ocular Toxicology.

Nominations from the membership will not be solicited. The OTSS Executive Committee will review and select the best paper among publications in Cutaneous and Ocular Toxicology between 01 January and 31 December of the year preceding the Society of Toxicology (SOT) Annual Meeting.

The award will be announced at the reception of the Ocular Toxicology Specialty Section (OTSS) held during the SOT Annual Meeting. The recipient will receive a certificate of recognition from Taylor & Francis at the OTSS reception and a subscription to Cutaneous and Ocular Toxicology.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders

There remains a scientific gap in understanding of the role of anti-TFPImediated hemostatic rebalancing in the context of inherited or non-hemophilic bleeding disorders. This competitive grant program encourages competitive submissions focsed on generating preclinical/foundational data exploring the therapeutic potential and mechanisms of TFPI modulation in bleeding disorders other than hemophilia.

Funding

• Individual projects requesting up to $50,000 USD will be considered. Request for study drug or compound is allowed (max $50,000 USD), additionally to the study project costs.
• Maximum project length is 1 year.

Susan G Komen Breast Cancer Foundation

The mission of Susan G. Komen® is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer.

Susan G. Komen Career Catalyst Research (CCR) Grants

Susan G. Komen Career Catalyst Research (CCR) Grants foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. We seek to support those who will emerge as the next key leaders in the fight against breast cancer.

CCR Research Focus: Research projects must be hypothesis-driven, breast cancer-focused studies. They may be considered basic, translational, clinical and/or population science in nature and should align with Komen’s research priorities and mission to save lives from breast cancer.